Thermo Fisher Scientific (TMO) Launches A New Microplate Reader, Does It Look Fairly Valued?

Thermo Fisher Scientific (TMO) has introduced the Multiskan Ease Absorbance Microplate Reader, a focused single mode instrument designed for labs that rely on routine absorbance assays and have tighter budgeting needs.

Thermo Fisher Scientific's latest product launch comes at a time when momentum in the shares has been building, with a 30-day share price return of 4.31% and a 90-day share price return of 29.83%. This has contributed to a 1-year total shareholder return of 29.78%, indicating stronger recent enthusiasm compared with longer term results over three and five years.

Scan Thermo Fisher Scientific alongside other lab-focused businesses that are benefiting from demand for dependable equipment through a curated list of list of solid balance sheet and fundamentals (23 results)

Thermo Fisher Scientific appears to be a powerful lab infrastructure giant, and the recent 90-day surge puts that strength in the spotlight. The key question now is whether the current share price already reflects it.

Most Popular Narrative: 3% Undervalued

Thermo Fisher Scientific closed at $613.62, a touch below the most followed fair value estimate of $631.42. This frames the current optimism around the stock.

Strong momentum in high-impact innovation, evidenced by next-generation analytical tools like the Orbitrap mass spectrometers and AI integration into drug development workflows, positions Thermo Fisher to capture incremental share as genomics and precision medicine proliferate, structurally boosting future revenues and margins.

See why 92 investors see Thermo Fisher Scientific as 3% undervalued.

Result: Fair Value of $631.42 (UNDERVALUED)

Still, Thermo Fisher Scientific faces real pressure if China weakness persists or if academic and government funding stays soft, which could undercut that 3% undervalued narrative.

Find out about the key risks to this Thermo Fisher Scientific narrative.

Next Steps

Sentiment around Thermo Fisher Scientific is clearly split, with investors weighing both opportunity and concern. Move quickly to review the underlying data and form your own stance by checking the 2 key rewards and 1 important warning sign.

Looking for more Thermo Fisher Scientific sized ideas?

Do not stop with Thermo Fisher Scientific. Use the Simply Wall Street Screener to quickly surface fresh opportunities that match the kind of edge you are hunting.

• Target quality at a discount by scanning companies that combine strong fundamentals with appealing pricing using 35 high quality undervalued stocks.
• Strengthen the defensive side of your portfolio and cut down on fragile balance sheets by reviewing a focused 11 resilient stocks with low risk scores.
• Spot potential future leaders early by tracking financially robust smaller players filtered through a 15 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com